COVID-19 antibody drug likely works against Omicron, companies say
The preliminary findings haven’t yet been peer-reviewed.
Tranexamic acid does not reduce risk of death in GI bleed
In patients with GI bleeding, does high-dose tranexamic acid (TXA) reduce the risk of death?
Second U.S. COVID-19 case caused by Omicron found
“This news is concerning, but it is not a surprise.”
SGLT2 inhibitor use tied to fewer atrial arrhythmias
First Omicron variant case identified in U.S.
“All close contacts have been contacted and have tested negative.”
Bedside frailty assessment can determine when CPR will be nonbeneficial
How does frailty impact survival after inpatient cardiac arrest in older adults?
Moderna warns of material drop in vaccine efficacy against Omicron
“There is no world, I think, where [the effectiveness] is the same level … we had with Delta.”
Children and COVID: New cases, vaccinations both decline
Despite the drop in cases, the weekly count still exceeded 100,000 for the 16th week in a row.
Fauci: Omicron ‘very different from other variants’
“Although partial immune escape may occur, vaccines, particularly boosters, give a level of antibodies that even with variants like Delta give you...
FDA panel backs first pill for COVID-19 by a small margin
If authorized by the agency, molnupiravir would be first antiviral agent available as a pill to treat COVID-19.